Eiger BioPharmaceuticals Inc
(OTCPK:EIGRQ)
$
3.33
0 (0%)
Market Cap: 4.93 Mil
Enterprise Value: 20.69 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 38/100 - Eiger BioPharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptDec 28, 2023
- Eiger BioPharmaceuticals Inc to Host Business Update Call TranscriptJun 29, 2023
- Eiger BioPharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 15, 2023
- Eiger BioPharmaceuticals Inc to Discuss Phase 3 D-LIVR Study Results of Lonafarnib-based Treatments in Hepatitis Delta Virus (HDV) Call TranscriptDec 08, 2022
- Q3 2022 Eiger BioPharmaceuticals Inc Earnings Call TranscriptNov 03, 2022$139.5 (-3.53%)Earnings
- Eiger BioPharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 18, 2022
- Eiger BioPharmaceuticals Inc at Ladenburg Thalmann Healthcare Conference TranscriptSep 29, 2022
- Q2 2022 Eiger BioPharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$289.5 (+3.54%)Earnings
- Eiger BioPharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Eiger BioPharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Q1 2022 Eiger BioPharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$184.5 (-8.89%)Earnings
- Eiger BioPharmaceuticals Inc to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19- Conference Call TranscriptMar 17, 2022
- Q4 2021 Eiger BioPharmaceuticals Inc Earnings Call TranscriptMar 10, 2022$132.6 (-3.07%)Earnings
- Eiger BioPharmaceuticals Inc Virtual Key Opinion Leader Event on Hepatitis Delta Virus TranscriptNov 15, 2021
- Q3 2021 Eiger BioPharmaceuticals Inc Earnings Call TranscriptNov 04, 2021$238.5 (+1.27%)Earnings
- Q2 2021 Eiger BioPharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$246.9 (+8.58%)Earnings
- Eiger BioPharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Q1 2021 Eiger BioPharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$259.5 (-6.28%)Earnings
- Eiger BioPharmaceuticals Inc Call to Discuss Zokinvy FDA Approval TranscriptNov 23, 2020
- Eiger BioPharmaceuticals Inc, Applied Therapeutics, Ultragenyx Pharmaceutical, Dicerna Pharmaceuticals, and Imara Inc at Citi BioPharma Conference (Virtual) - Panel TranscriptSep 09, 2020
Sorry the transcript is not found. Please try another one.